Celularity Inc. - Class A (CELU) earnings
CELU earnings moved a median of 0.00% by the close. Quarterly and annual CELU reports and results, each read against the price at its own news timestamp. Back to the CELU overview →
35 measured CELU earnings events.
Where these CELU earnings landedvs 35 measured CELU earnings reactions
| Middle 50% of CELU earnings reactions | -3.98% to +2.17% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 35 |
Point-in-time · zero look-ahead
Half of the 35 CELU earnings events with a measured close landed between -3.98% and +2.17%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Celularity Inc For: Mar 31 | SEC filing · Form 10-Q | -1.46% | -1.46% | |
| Form NT 10-Q Celularity Inc For: Jun 30 | SEC filing · Form NT | +0.00% | +2.35% | |
| Celularity Receives Nasdaq Notice Regarding Form 10-Q | Press release | -0.99% | +5.94% | |
| Form NT 10-Q Celularity Inc For: Mar 31 | SEC filing · Form NT | +0.00% | -1.19% | |
| Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation | Press release | -4.76% | -6.28% | |
| Form 10-K Celularity Inc For: Dec 31 | SEC filing · Form 10-K | +3.39% | -6.18% | |
| Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing | Press release | +3.89% | +0.81% | |
| Form NT 10-K Celularity Inc For: Dec 31 | SEC filing · Form NT | +0.00% | -1.50% | |
| Form 10-Q Celularity Inc For: Sep 30 | SEC filing · Form 10-Q | +0.59% | -9.52% | |
| Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance | Press release | -3.31% | -0.78% | |
| Form 10-Q Celularity Inc For: Jun 30 | SEC filing · Form 10-Q | -0.97% | -17.74% | |
| Form 10-Q Celularity Inc For: Mar 31 | SEC filing · Form 10-Q | -0.97% | -17.74% | |
| Celularity Receives Nasdaq Notice Regarding Form 10-Q | Press release | -1.04% | +0.00% | |
| Celularity Receives Nasdaq Notice Regarding Form 10-Q | Press release | +1.42% | +1.36% | |
| Form 10-K/A Celularity Inc For: Dec 31 | SEC filing · Form 10-K | +0.98% | +21.46% | |
| Form 10-K Celularity Inc For: Dec 31 | SEC filing · Form 10-K | -2.22% | -7.22% | |
| Form NT 10-K Celularity Inc For: Dec 31 | SEC filing · Form NT | -0.30% | +2.38% | |
| Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023 | Press release | +6.93% | +2.17% | |
| Form 10-Q Celularity Inc For: Sep 30 | SEC filing · Form 10-Q | +6.93% | +2.17% | |
| Form NT 10-Q Celularity Inc For: Sep 30 | SEC filing · Form NT | +0.21% | +18.38% | |
| Form 10-Q Celularity Inc For: Jun 30 | SEC filing · Form 10-Q | +8.16% | +110.20% | |
| Form 10-Q Celularity Inc For: Mar 31 | SEC filing · Form 10-Q | -6.28% | -11.56% | |
| Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing | Press release | +6.11% | -2.89% | |
| Form NT 10-Q Celularity Inc For: Jun 30 | SEC filing · Form NT | — | +1.63% | |
| Form 10-K Celularity Inc For: Dec 31 | SEC filing · Form 10-K | +1.61% | +1.61% | |
| Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing | Press release | +0.00% | -3.71% | |
| Form NT 10-Q Celularity Inc For: Mar 31 | SEC filing · Form NT | +1.21% | -8.13% | |
| Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing | Press release | +5.00% | +2.00% | |
| Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products | Press release | +2.33% | -2.33% | |
| Form NT 10-K Celularity Inc For: Dec 31 | SEC filing · Form NT | +1.18% | -1.77% | |
| Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline | Press release | +1.10% | +19.05% | |
| Celularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023 | Press release | +22.05% | +15.16% | |
| Form 10-Q Celularity Inc For: Sep 30 | SEC filing · Form 10-Q | -2.68% | +0.36% | |
| Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing | Press release | — | +0.00% | |
| Form NT 10-Q Celularity Inc For: Sep 30 | SEC filing · Form NT | -5.71% | -4.24% |
Keep exploring
More CELU: analyst actions → · SEC filings → · CELU overview →